BioSpace News Archive

AION Labs Launches AI Startup for De Novo Antibody Design

AION Labs, the first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced today the formation of DenovAI, the lab’s second startup approved by the Israel Innovation Authority.

February 28, 2023

·

6 min read

Pharm Country

Tory Burch Turns to Modern Meadow Bio-Alloy™ For Ella Bio Tote

Modern Meadow announced its Bio-Alloy™ proprietary protein-based technology is coming to the Tory Burch runway as the American fashion brand debuts its first-ever plant-based leather alternative tote, the Ella Bio, an evolution of the iconic Ella tote.

February 28, 2023

·

3 min read

UltraSight Granted Patent for Real-Time Guidance Ultrasound Technology

Today, UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced it has been granted a patent for real-time guidance of ultrasound devices.

February 28, 2023

·

2 min read

Pharm Country

Xylyx Bio launches new website to showcase growing portfolio of regenerative biotechnologies

Xylyx Bio, a New York-based regenerative medicine company leading the development of advanced biomaterials and biosystems, is proud to announce the launch of their redesigned website showcasing the company’s growing portfolio of regenerative biotechnologies.

February 28, 2023

·

1 min read

Biotech Beach

Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg

Endonovo Therapeutics, Inc. (OTCQB: ENDV), a medical device company specializing in pulsed electromagnetic field (PEMF) technology, announced today it will hold a question and answer session for shareholders on March 9, 2023 at 4:30pm EST with Ira Weisberg, President of Endonovo’s Medical Division.

February 28, 2023

·

4 min read

Genetown

Synergy Laboratories Taps SOPHiA GENETICS Technology for New Cancer Profiling Solution

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced that Synergy Oncology, part of Synergy Laboratories, a full-service diagnostic laboratory based in Mobile, Alabama, will use SOPHiA DDM™ to develop a new cancer profiling solution.

February 28, 2023

·

5 min read

BioCapital

FDA Takes Action to Restrict Unlawful Import of Xylazine

Today, the U.S. Food and Drug Administration announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage form drug products into the country to address a growing public health concern.

February 28, 2023

·

3 min read

Pharm Country

Hillstream BioPharma to Attend the 35th Annual ROTH Conference on March 12-14, 2023

Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”) will be attending the 35th Annual ROTH Conference, being held March 12–14 at The Ritz-Carlton Hotel in Dana Point, California.

February 28, 2023

·

4 min read

Business

Kytopen Expands Scientific Advisory Board Joined by Bioengineering Expert Mikhail Shapiro, Ph.D.

Kytopen, an MIT-spin out and biotechnology company leading advancements in high-throughput cellular and genome engineering platforms, today announced the addition of leading chemical and medical engineering expert Mikhail Shapiro, Ph.D. to the Kytopen Scientific Advisory Board (SAB).

February 28, 2023

·

2 min read

Ascelia Pharma meets major milestone with patient enrollment completion of Phase 3 Study for Orviglance, novel MRI contrast agent for patients with kidney impairment

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced the successful completion of patient enrollment in the company’s pivotal phase 3 clinical study, SPARKLE, with the lead candidate drug Orviglance®.

February 28, 2023

·

3 min read